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Abstract: A 30-year-old male with no previous history of neoplastic disease presented with a 5 cm large testicular 
tumor. Routine histopathological examination and immunohistochemical investigation showed a classical semi-
noma with a contiguous 8 mm large nodule.  The nodule was separated from the tunica albuginea by tubuli semi-
niferi showing intratesticular germ cell neoplasi not otherwise specified (NOS). The nodule was composed of spin-
dle cells with low-grade nuclear atypia, nuclear and cytoplasmic S100 protein immunoreactivity in 15% of the 
cells and a proliferative activity of up to 20%. No other germ cell tumor components were found. To the best of 
our knowledge, we herein present the first tumor of a pure classical seminoma with an associated low-grade sar-
comatous component. 
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Introduction 
 
Sarcomatous transformation with different 
histogenetic differentiation in spermatocytic 
seminoma are well known to occur [1-4], but 
there has been no case described where a 
sarcoma has occurred in a pure classical se-
minoma. We herein describe, to the best of 
our knowledge, the first case of a pure clas-
sical seminoma in which there was an asso-
ciated low-grade sarcomatous component. 
 
Clinical summary 
 
A 30-year-old male with no previous history of 
neoplastic disease presented with a 5 cm 
large testicular tumor. A radical inguinal orchi-
dectomy was performed. Adjuvant chemo-
therapy was administered. The patient is alive 
and well 12 months after surgery. 
 
Materials and methods 
 
A comprehensive immunohistochemical study 
was performed with routine antibodies accord-
ing to the instructions of the manufacturers. 
The following monoclonal antibodies were em-
ployed: CD56 (1B6, 1:100, Novocastra, New-
castle, UK), CD30 (Ber-H2, 1:100, DakoCyto-
mation, Glostrup, Denmark), CD31 (JC/70A, 
1:50, Dako, Glostrup, Denmark), CD34 
(QBEnd/10, 1:800, NeoMarkers, Wes-
tinghouse, CA, USA), inhibin (R1, 1:30, Bio-
Innovation, Oxford, UK), desmin (D33, 1:2000, 
DakoCytomation, Glostrup, Denmark), smooth 
muscle actin (1A4, DAKO, Glostrup, Denmark), 
p63 (4A4, 1:500, NeoMarkers, Westinghouse, 
CA, USA), calretinin (5A5, Novocastra, Newcas-
tle, UK), cytokeratins: (CAM 5.2, 1:200, Becton 
Dickinson, Erembogeden, Belgium), cytokera-
tin 5/6, D5/16B4, 1:100, DakoCytomation, 
Glostrup, Denmark), S100 protein (S1/61/69, 
1:50, Novocastra, Newcastle, UK), EMA (E29, 
1:500, Dako, Glostrup, Denmark), Ki-67 (MIB-
1, 1:1000, DakoCytomation, Glostrup, Den-
mark), p53 (DO-7, 1:50, DakoCytomation, Glo-
strup, Denmark), Melan A (A 103, 1:100, Da-
koCytomation, Glostrup, Denmark), MTF (D5, 
1:25, NeoMarkers, Westinghouse, CA, USA), 
MyoD1 (5.8A, 1:50, DakoCytomation, Carpin-
teria, CA, USA), HMB-45 (HMB45, 1:200, Da-
koCytomation, Carpinteria, CA, USA), vimentin 
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(V9, 1:1000, NeoMarkers, Westinghouse, CA, 
USA), ALK-1 (p80, 1:400, Novocastra, Newcas-
tle, UK), bcl-2 (clone 124, 1:300, DakoCytoma-
tion, Glostrup, Denmark). Polyclonal antibodies 
listed below were used for our study: myoglo-
bin (DakoCytomation, 1:1000, Glostrup, Den-
mark), CD117 (DakoCytomation, 1:150, Glo-
strup, Denmark), alpha-fetoprotein (DakoCy-
tomation, 1: 500, Glostrup, Denmark), hCG 
(DakoCytomation, 1: 2000, Glostrup, Den-
mark) and OCT ¾ (Santa Cruz, 1:3200, Vien-
na, Austria). A molecular genetic study was 
performed using FISH analysis with premixed 
probes 12p / CEP 12 (Vysis/Abbott, IL, USA) 
for isochromosome 12p and probe 9p21 (Vy-
sis/Abbott, IL, USA) to detect deletion of 9p21. 
 
Results 
 
The tumor was confined to the testis, i.e. did 
not grow through the tunica albuginea or into 
the epididymis. The size of the tumor was 5 cm 
and was homogenously grey on gross section. 
No necrotic areas were seen. 
 
The whole tumor was embedded in paraffin 
and 4μm thin sections were cut and stained 
with Hematoxylin and Eosin. Routine histo-
pathological examination showed a classical 
seminoma with no other germ cell tumor com-
ponents (Figure 1). In addition, there was an 8 
mm large nodule contiguous to the seminoma 
(Figure 2). The nodule was separated from the 
tunica albuginea by tubuli seminiferi showing 
intratesticular germ cell neoplasia, not other-
wise specified (NOS) (Figure 3). The lesional 
tissue in the nodule displayed a completely 
different morphology. It was composed of a 
well delineated, non-encapsulated, moderately 
cellular, spindle cell lesion with cells having 
slender cytoplasmic processes arranged in 
fascicles and with scattered intra-lesional lym-
phocytes (Figure 4). On high-power examina-
tion, lesional cells showed low-grade nuclear 
atypia. Mitotic figures were  easily found (Fig-
ure 5). The immunohistochemical study 
showed that lesional spindle cells were posi-
tive for vimentin (100% of cells) and S100 
protein (including nuclear positivity) in approx-
imately 15% of the cells (Figure 6). The neop-
lastic cells were negative for all other antibo-
dies. The proliferation index as measured with 
immunohistochemistry (Mib-1/Ki-67) was ap-
proximately 20% (Figure 7). In the molecular 
genetic study amplification of isochromosome 
12p (Figure 8), but no deletion of 9p21 was 
found in the seminomatous component. The 
FISH-study in the sarcomatous component was 
not successful. 
 
Discussion 
 
Spermatocytic seminoma occurring together 
with a sarcomatous component is a well rec-
ognized phenomenon [1-4]. Such tumors are 
usually diagnosed as high stage neoplasms 
with metastatic disease at time of surgery. The 
sarcomatous component in these tumors is 
 
 
Figure 1. Photomicrograph of a Hematoxylin and 
Eosin stained section from the main tumor com-
ponent showing histomorphological features of a 
classical seminoma. 
 
Figure 2. Photomicrograph of a whole mounted 
section stained with Hematoxylin and Eosin of a 
classical seminoma with a 8 mm nodule in the 
periphery (depicted by the arrows) with a spindle 
cell lesion with a low-grade sarcomatous mor-
phology. 
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variable (rhabdomyosarcoma, chondro-
sarcoma or undifferentiated sarcoma). Our 
case differs from spermatocytic seminoma by 
the absence of the characteristic three cell 
population of spermatogonia-like cells, small 
lymphocyte-like cells and intermediate cells. 
Moreover, the tumor lacked the oedematous 
stroma typically seen in spermatocytic semi-
noma. That the germ cell tumor presented 
herein is a classical and not a spermatocytic 
seminoma is supported by the molecular ge-
netic study showing amplification of isochro-
mosome 12p and lack of deletion of 9p21. 
 
No tumor similar to the one presented here 
has been described in the testis, but there are 
two similar cases on record. One case with a 
rhabdomyosarcoma occurring in a dysgermi-
noma of the ovary where no other germ cell 
tumor (GCT) component was found [5] and one 
case with the development of rhabdomyosar-
coma in a retroperitoneal GCT composed of a 
pure seminoma [6]. Generally, primary testicu-
lar sarcomas are extremely rare neoplasms 
with only a limited number of cases reported in 
the literature. These sarcomas have been va-
riously classified [7-14 15, 16 1, 17-22]. Testi-
cular teratomas with somatic malignant trans-
formation including sarcoma are rare but well 
documented and characterized [20, 22-24]. 
Furthermore, there are primary testicular tu-
mors on record that are classified as “malig-
 
 
Figure 3. Photomicrograph from the immunohistochemical study; OCT 3/4 showing tubuli seminiferi with 
intratesticular germ cell neoplasia NOS located contiguous to the low-grade sarcoma. The nuclear positivity 
is depicted by arrows.   
Figure 4A,B. Photomicrographs of Hematoxylin and Eosin stained sections from the low-grade sarcomatous 
area in a seminoma showing moderate cellularity. Neoplastic cells have a predominantly spindle cell mor-
phology. There are intralesional lymphocytes. 
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nant mixed gonadal stromal tumor with me-
senchymal heterologous elements of the tes-
tis” [21], “testicular mixed gonadal stromal 
tumor with osteosarcoma component” [25], 
“sarcomatoid Leydig cell tumor” [26] and 
“Leydig cell tumors with adipose differentia-
tion, calcification, ossification, and spindle-
shaped tumor cells” [27]. In a recent, and to 
date the largest, study on testicular GCTs with 
sarcomatous components by Guo et al [28], 
33 cases were presented. Of these 33 cases, 
19 had a sarcomatous component in the testi-
cular tumor only, in 11 cases the sarcoma was 
found in the metastasis only and in 3 cases 
both in the testicular tumor and the metasta-
sis. All testicular GCTs contained a teratomat-
ous component (pure in 3 cases and mixed 
GCTs in the rest). In none of the cases was 
there a pure classical seminoma associated 
with a sarcoma. As inclusion criterion, Guo et 
al employed that suggested by Ulbright et al 
[29] (“Expansile sarcomatous tumor growth of 
at least one low-power field (4 x objective) re-
placing the GCT component”), a quantitative 
criterion that was met by the sarcomatous 
component in the case presented by us. In 
only one of the cases presented by Guo et al, 
was there a low-grade sarcoma (“low-grade 
unclassified myxoid sarcoma”), the rest were 
high-grade sarcomatous neoplasms. Based on 
the verbal description and the presented pic-
ture (Figure 4) in the paper by Guo et al, this 
low-grade unclassified myxoid sarcoma show 
morphological similarities to the low-grade 
sarcomatous component presented herein. 
However, the authors found no immunohisto-
chemical evidence suggesting any specific line 
of differentiation in this case (also true for ad-
ditional four cases in their study). This is in 
contrast to the distinct immunoreactivity for 
S100 protein that was detected in our case.  
Based on (1) the presence of  low-grade but 
distinct nuclear atypia and (2) a high prolifera-
tive activity and (3) the lack of histological fea-
tures as well as immunohistochemical findings 
in line with  any previously described benign 
entity in this anatomical location, we conclude 
Figure 7. Photomicrograph from the low-grade 
sarcomatous area in a classical seminoma that 
have been immunohistochemically stained for Ki-
67 protein. About 20% of neoplastic cells show 
nuclear positive reaction. 
 
Figure 5. Photomicrograph (High-power) of Hema-
toxylin and Eosin stained section from the sarco-
matous area in a classical seminoma showing 
nuclear abnormalities, i.e. hyperchromasia and 
irregular shape and three mitotic figures (arrows). 
 
 
 
 
Figure 6. Photomicrograph of section from the 
low-grade sarcomatous area in a classical semi-
noma that have been immunohistochemically 
stained for S100 protein. About 15% of neoplas-
tic cells show both nuclear and cytoplasmic reac-
tivity for S100 protein. 
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that the spindle cell component in our case 
represents a low-grade sarcoma. The well cir-
cumscribed, non-encapsulated border of the 
spindle cell lesion does not preclude a diagno-
sis of sarcoma. Small sarcomas of various 
types are well known for having a relatively 
good circumscription. This is true for example 
in minute synovial sarcomas of the hands and 
feet [30] and small superficial epithelioid sar-
comas as well as small alveolar soft part sar-
comas in the tongue and endocervix. We found 
no light microscopical or immunohistochemi-
cal evidence of melanocytic, endothelial, 
smooth muscle, rhabdomyoblastic, myo-
fibroblastic or mesothelial differentiation. The 
positivity for S100 protein may indicate a peri-
pheral nerve sheath differentiation and it is 
well known that malignant peripheral nerve 
sheath tumors (MPNST) can be very well diffe-
rentiated and that positivity for the S100 pro-
tein in MPNST is usually focal, if positive at all. 
However, we cannot substantiate a Schwann-
cell differentiation with ultrastructural findings 
because material for an ultrastructural study 
was lacking. The negative immunostaining for 
calretinin and inhibin argues against a sarco-
matous or spindle cell variant of Leydig-Sertoli 
cell origin A granulomatous and/or fibrotic 
reaction should also be considered. These 
types of tissue reactions can be seen in clas-
sical seminoma and can, at times, be exten-
sive. However, we do not believe that the spin-
dle cell lesion described and characterized in 
this paper is a reactive process. Firstly, there 
was no granulomatous change in either the 
spindle cell - low grade sarcomatous - lesion or 
the seminomatous component. Secondly, 
there was no substantial amount of collagen-
ous matrix - fibrosis in neither the low grade 
sarcomatous nor the seminomatous compo-
nent. The lack of immunohistochemical reac-
tivity for smooth muscle actin and to some 
extent the ALK-1 protein as well as the ab-
sence of plasma cells are findings that are not 
consistent with an inflammatory myofibroblas-
tic tumor. A pseudosarcomatous myofibroblas-
tic process (fibrous periorchitis or a prolifera-
tive funiculitis-type lesion) typically displays 
tissue-culture type lesional cells with promi-
nent nucleoli which is in contrast to the slend-
er spindle cells with nuclear hyperchromasia 
lacking prominent nucleoli in our case Moreo-
ver, the immunohistochemical study failed to 
reveal any evidence of myofibroblastic diffe-
rentiation. The possibility of a testicular fibro-
ma of gonadal stromal origin or of testicular 
tunics has to be seriously considered. Howev-
er, as described by  Jones et al 31 in three 
testicular fibromas of gonadal stromal origin, 
these rare neoplasms show morphological 
features identical to those of ovarian fibromas 
and immunohistochemically all tumors in their 
study were negative for S100 protein and two 
of the three presented tumors were focally 
positive for actin and desmin. Moreover, their 
tumors lacked an inflammatory cell compo-
nent and the acellular plaques of hyalinized 
collagen that the authors found were com-
pletely lacking in our case. Hence, both the 
histological features and immunohistochemi-
cal findings in the series of fibromas of gonad-
al stromal origin by Jones et al are in sharp 
contrast to the findings in our case. Similarly, 
all the five cases of fibromas of testicular tun-
ics presented by the same authors were nega-
tive for S100 protein in their immunohisto-
chemical study and three cases were positive 
for CD34. The lesional cells displayed bland 
cytomorphological features without nuclear 
atypia and they found no mitotic activity. The 
solitary fibrous tumor-like areas reported by 
the authors were completely lacking in our 
case. Again, both the immunohistochemical 
findings and histological features of the fibro-
mas of testicular tunics that Jones et al de-
scribe are significantly different from the low-
 
Figure 8. Photomicrographs from the molecular 
genetic study showing a nucleus from the clas-
sical seminomatous component. FISH analysis 
using 12p (Spectrum Green) and CEP 12 (Spec-
trum Orange) probe. Visualization under Dual 
Band Pass filter. Amplified five green (12p) and 
two red (CEP 12) signals are presented in the 
nucleus.  
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grade sarcomatous component presented 
here. Regarding the histogenesis of the sar-
comatous component in the case presented 
herein, several hypotheses can be put forward: 
(1) There could have been a teratomatous 
component (as in the cases presented by Guo 
et al [28]) within the tumor that had been 
overgrown by the seminomatous component 
or was so small that it was not detected, al-
though the whole tumor was embedded. (2) 
The sarcoma could be a coincidentally devel-
oped tumor or (3) The sarcomatous compo-
nent could be derived from the classical semi-
noma. We tried to investigate (3) with a mole-
cular genetic study but as stated above, this 
was not successful. Thus, the histogenetic 
origin of the sarcoma component remains un-
clear. 
 
The case was recently diagnosed precluding 
any conclusion regarding the potential impact 
of such a sarcomatous component on progno-
sis. However, based on the fact that the sar-
comatous area was small and did not show 
any high-grade malignant features, we feel 
that a negative impact on prognosis is not to 
be expected. Moreover, the results in the study 
by Guo et al [28] suggest that patients with a 
sarcomatous component confined to the testi-
cular GCT may not have a higher risk of mor-
tality than those at a comparable stage with-
out a sarcomatous component. In summary, 
we describe for the first time a low-grade sar-
coma occurring together with a pure classical 
seminoma and immunohistochemically cha-
racterize this and discuss its histogenesis. We 
suggest that, based on morphology and the 
focal positive immunoreactivity for S100 pro-
tein, this low-grade sarcoma may be of 
Schwann-cell origin. 
 
Please address all correspondences to: Fredrik 
Petersson, MD, Department of Pathology, National 
University Health System,5 Lower Kent Ridge Road, 
Singapore 119074, Phone: +6597714890, Fax: 
+6567780671, E-mail: fredrikpetersson@live.se 
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